Meredith Manning

Insider Reports History

Entity
Individual
Location
C/O Restorbio, Inc., 500 Boylston St., 12 Th Floor, Boston, MA
Signature
/s/ Anish Bhatnagar, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Meredith Manning:

Stock Role Class Num Shares Value Price $ Report Date Ownership
SOLENO THERAPEUTICS INC Chief Commercial Officer Common Stock 45.4K $3.04M $67.04 Mar 27, 2025 Direct
SOLENO THERAPEUTICS INC Chief Commercial Officer Employee stock option (right to buy) 91K Mar 27, 2025 Direct

Insider Reports Filed by Meredith Manning

Symbol Company Period Transactions Value $ Form Type Date Filed Role
SLNO SOLENO THERAPEUTICS INC Mar 27, 2025 11 -$1.33M 4 Mar 31, 2025 Chief Commercial Officer
SLNO SOLENO THERAPEUTICS INC Jan 21, 2025 2 $0 4 Jan 23, 2025 Chief Commercial Officer
SLNO SOLENO THERAPEUTICS INC Jul 17, 2024 1 $0 4 Jul 19, 2024 Chief Commercial Officer
SLNO SOLENO THERAPEUTICS INC Apr 22, 2024 0 $0 3 Apr 30, 2024 Chief Commercial Officer